Century Therapeutics: Funding, Investors & Team (Sep 2026)
Century Therapeutics creates a platform for cell therapy using allogeneic iPSC-derived cells that combine gene editing, protein engineering, technical advancements, and manufacturing skills. This platform produces NK and T cell therapies derived from iPSCs for both hematological and solid tumor cancers that have a high level of medical need.
Century Therapeutics has raised $195M across 2 funding rounds on record, the most recent an undisclosed round of $135M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Century Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Century Therapeutics Funding Rounds
Century Therapeutics raised $60.0M in an undisclosed round announced in Apr 2024.
1.8 years later, an undisclosed round of $135M was announced in Jan 2026.
Century Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Century Therapeutics Funding Compared to Other Biotechnology Startups
Century Therapeutics' latest round of $135M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Century Therapeutics in Biotechnology and Philadelphia
Companies Similar to Century Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Century Therapeutics Funding FAQs
What does Century Therapeutics do?
Century Therapeutics creates a platform for cell therapy using allogeneic iPSC-derived cells that combine gene editing, protein engineering, technical advancements, and manufacturing skills. This platform produces NK and T cell therapies derived from iPSCs for both hematological and solid tumor cancers that have a high level of medical need.
How much funding has Century Therapeutics raised?
Century Therapeutics has raised $195M across 2 rounds on record. The most recent is an undisclosed round of $135M announced in Jan 2026.
When did Century Therapeutics last raise funding?
Century Therapeutics' most recent funding round on record is an undisclosed round of $135M, announced in Jan 2026.
Who founded Century Therapeutics?
FundedIQ lists Marcela Maus (Founder) at Century Therapeutics.
Where is Century Therapeutics headquartered?
Century Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Century Therapeutics have?
Century Therapeutics is in the 101-250 employee band.
How does Century Therapeutics' funding compare to other Biotechnology startups?
Century Therapeutics' latest round of $135M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Century Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Century Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.